UBM Group

20th Joseph Tito st., 3rd floor

11843 New Nozha

Egypt

A group of Pharmaceutical & Biological industries is a privately shareholder company Established since 1997 with +20 years, +600 employees

Pharmaceutical, Biological, Vaccines

Premium HealthCare’s EGM approves over $33mln acquisition deals

The EGX-listed firm will fully acquire five companies for a total value of EGP 1.46 billion.

This new medicine is now available at 22 specialised units nationwide, which provide free treatment to patients.

The WHO benchmarking process, conducted using its GBT, evaluates regulatory systems against more than 250 indicators.

The company aims to foster investment in Egypt's healthcare system and promote opportunities in the Egyptian health sector globally.

This initiative marks a critical step toward achieving self-sufficiency in drug production and addressing the growing needs of diabetic populations.

Health Events

Egy Beauty Expo 24.05.2025

Pharmaconex 01.09.2025

Download the free 180 pages report